Browse by Nurse Practitioner Items

Nurse practitioner PBS prescribing

MEDICINES WHICH MAY BE PRESCRIBED BY AUTHORISED NURSE PRACTITIONERS

From 1 September 2010, nurse practitioners endorsed to prescribe under state or territory legislation can apply for approval as PBS prescribers (authorised nurse practitioners) Information for nurse practitioners to become authorised PBS prescribers is available from the Department of Human Services.

The medicines listed for prescribing by authorised nurse practitioners from 1 November 2010 are identified by ‘NP’ in the PBS Schedule. Nurse practitioners must not write PBS prescriptions for other medicines.

PBS prescribing is limited by a nurse practitioner’s scope of practice, and state and territory prescribing rights. Prescribing of PBS medicines is also contingent on a prescriber being an authorised nurse practitioner and having collaborative arrangements in place, as required by amendments to the National Health Act 1953.

The Pharmaceutical Benefits Advisory Committee (PBAC) is responsible for making recommendations to the Minister for Health regarding medicines for prescribing by authorised nurse practitioners.

Further to prescribing within collaborative arrangements, certain medicines also have additional conditions for prescribing by nurse practitioners, as recommended by the PBAC. These medicines are identified by the codes ‘CTO’ for continuation therapy only or ‘SCM’ for prescribing within a shared care model, as outlined below:

  • Continuing therapy only model

Where the patient’s treatment and prescribing of a medicine has been initiated by a medical practitioner, but prescribing is continued by a nurse practitioner. (This is similar to existing arrangements between specialists and medical practitioners for prescribing certain medicines.)

  • Shared care model

Where care is shared between a nurse practitioner and medical practitioner in a formalised arrangement with an agreed plan to manage the patient, in a patientcentred model of care. The details surrounding shared care arrangements will depend on the practitioners involved, patient needs and the healthcare context.

Some medicines are included in more than one section of the Schedule, and for more than one prescriber type. For a prescription to be eligible for subsidy, prescribers must ensure that they prescribe under the PBS only those medicines, and in accordance with the restrictions, listed for their prescriber type. Listing details for the same product may differ between sections and different PBS item codes apply for each prescriber type.

Nurse practitioner PBS prescriptions are identifiable by colour, and include the indicator ‘NP’ on personalised forms and a tick box on non-personalised (blank) forms.

Prescriptions must include the nurse practitioner’s PBS prescriber number. For unrestricted and restricted PBS medicines, midwives/nurse practitioners can use the personalised or non-personalised PBS prescriber forms.  For authority required and authority required (streamlined) PBS medicines, midwives/nurse practitioners can use the authority personalised or non-personalised PBS prescriber forms.  Nurse practitioner PBS prescriptions may include repeats. 

Regulation 49 applies for nurse practitioner prescribing. A nurse practitioner can direct that original and repeat supplies of pharmaceutical benefits be supplied at the one time, if certain conditions are satisfied.

Authority prescriptions: Authority prescriptions for authority required items, or for increased quantities or repeats, require prior approval from the Department of Human Services for each prescription. (Refer to Prescribing Medicines — Information for PBS prescribers and Supplying medicines — What Pharmacists Need to Know, for more information on authority prescriptions.)

State and territory requirements: Nurse practitioners may prescribe medicines as private prescriptions according to their state/territory prescribing accreditation. The medicines which can be prescribed differ between states and territories. It is the nurse practitioner’s responsibility to ensure adherence to State/Territory law for all prescriptions (PBS and private) and additionally to all PBS requirements for PBS prescriptions.

  • Legend
  • PPalliative care items
  • MPMedical Practitioner
  • MWMidwife
  • NPNurse Practitioner
Prescriber code Item code Name, manner of administration and form & strength Max qty
packs
Max qty
units
No. of
repeats
MPNP 2729P BACLOFENbaclofen 10 mg tablet, 100 1 100 5
MPNP 2730Q BACLOFENbaclofen 25 mg tablet, 100 1 100 5
MPNP 11351K BALSALAZIDEbalsalazide sodium 750 mg capsule, 280 1 280 5
MPNP 8409N BECLOMETASONEbeclometasone dipropionate 100 microgram/actuation breath activated inhalation, 200 actuations 1 1 5
MPNP 8406K BECLOMETASONEbeclometasone dipropionate 50 microgram/actuation pressurised inhalation, 200 actuations 1 1 5
MPNP 8407L BECLOMETASONEbeclometasone dipropionate 100 microgram/actuation pressurised inhalation, 200 actuations 1 1 5
MPNP 8408M BECLOMETASONEbeclometasone dipropionate 50 microgram/actuation breath activated inhalation, 200 actuations 1 1 5
MPNP 2267H BENZATHINE BENZYLPENICILLINbenzathine benzylpenicillin 1.2 million units (900 mg)/2.3 mL injection, 10 x 2.3 mL syringes 1 10 0
MPNP 2362H BENZATROPINEbenzatropine mesilate 2 mg tablet, 60 1 60 2
MPNP 11255J BENZATROPINEbenzatropine mesilate 2 mg/2 mL injection, 5 x 2 mL vials 1 5 0
MPNP 11265X BENZATROPINEbenzatropine mesilate 2 mg/2 mL injection, 5 x 2 mL vials 1 5 0
MPNP 1121B BENZYDAMINEbenzydamine hydrochloride 0.15% mouthwash, 500 mL 1 1 1
MPNP 5385K BENZYDAMINEbenzydamine hydrochloride 0.15% mouthwash, 500 mL 1 1 3
MPMWNP 1775K BENZYLPENICILLINbenzylpenicillin 600 mg injection, 1 vial 10 10 1
MPNP 3486L BENZYLPENICILLINbenzylpenicillin 600 mg injection, 1 vial 5 5 0
MPNP 2647H BENZYLPENICILLINbenzylpenicillin 3 g injection, 1 vial 10 10 0
MPNP 3487M BENZYLPENICILLINbenzylpenicillin 3 g injection, 1 vial 1 1 0
MPNP 2694T BETAMETHASONE ACETATE + BETAMETHASONE SODIUM PHOSPHATEbetamethasone (as sodium phosphate) 2.96 mg/mL + betamethasone (as acetate) 2.71 mg/mL injection, 5 x 1 mL ampoules 1 5 0
MPNP 1119X BETAMETHASONE DIPROPIONATEbetamethasone (as dipropionate) 0.05% ointment, 15 g 1 1 1
MPNP 10795E BETAMETHASONE DIPROPIONATEbetamethasone (as dipropionate) 0.05% ointment, 15 g 2 2 5
MPNP 10820L BETAMETHASONE DIPROPIONATEbetamethasone (as dipropionate) 0.05% ointment, 15 g 4 4 5
MPNP 10821M BETAMETHASONE DIPROPIONATEbetamethasone (as dipropionate) 0.05% ointment, 15 g 6 6 5
MPNP 10816G BETAMETHASONE DIPROPIONATEbetamethasone (as dipropionate) 0.05% ointment, 15 g 8 8 5
MPNP 10823P BETAMETHASONE DIPROPIONATEbetamethasone (as dipropionate) 0.05% ointment, 15 g 10 10 5
MPNP 1115Q BETAMETHASONE DIPROPIONATEbetamethasone (as dipropionate) 0.05% cream, 15 g 1 1 1
MPNP 10824Q BETAMETHASONE DIPROPIONATEbetamethasone (as dipropionate) 0.05% cream, 15 g 2 2 5
MPNP 10800K BETAMETHASONE DIPROPIONATEbetamethasone (as dipropionate) 0.05% cream, 15 g 4 4 5
MPNP 10813D BETAMETHASONE DIPROPIONATEbetamethasone (as dipropionate) 0.05% cream, 15 g 6 6 5
MPNP 10801L BETAMETHASONE DIPROPIONATEbetamethasone (as dipropionate) 0.05% cream, 15 g 8 8 5
MPNP 10802M BETAMETHASONE DIPROPIONATEbetamethasone (as dipropionate) 0.05% cream, 15 g 10 10 5
MPNP 2812B BETAMETHASONE VALERATEbetamethasone (as valerate) 0.02% cream, 100 g 2 2 0
MPNP 2813C BETAMETHASONE VALERATEbetamethasone (as valerate) 0.05% cream, 15 g 1 1 1
MPNP 10799J BETAMETHASONE VALERATEbetamethasone (as valerate) 0.05% cream, 15 g 2 2 5
MPNP 10794D BETAMETHASONE VALERATEbetamethasone (as valerate) 0.05% cream, 15 g 4 4 5
MPNP 10808W BETAMETHASONE VALERATEbetamethasone (as valerate) 0.05% cream, 15 g 6 6 5
MPNP 10807T BETAMETHASONE VALERATEbetamethasone (as valerate) 0.05% cream, 15 g 8 8 5
MPNP 10810Y BETAMETHASONE VALERATEbetamethasone (as valerate) 0.05% cream, 15 g 10 10 5
MPNP 1062X BETHANECHOLbethanechol chloride 10 mg tablet, 100 1 100 2
MPNP 8094B BICALUTAMIDEbicalutamide 50 mg tablet, 28 1 28 5
MPNP 9470K BICARBONATEsodium bicarbonate 840 mg capsule, 100 1 100 2
MPNP 2544X BIPERIDENbiperiden hydrochloride 2 mg tablet, 100 2 200 2
MPNP 1259G BISACODYLbisacodyl 5 mg enteric tablet, 200 1 200 2
MPNP 5301B BISACODYLbisacodyl 5 mg enteric tablet, 200 1 200 3
MPNP 1260H BISACODYLbisacodyl 10 mg suppository, 10 3 3 5
MPNP 5303D BISACODYLbisacodyl 10 mg suppository, 10 3 3 3
MPNP 1263L BISACODYLbisacodyl 10 mg/5 mL enema, 25 x 5 mL 1 1 2
MPNP 5302C BISACODYLbisacodyl 10 mg/5 mL enema, 25 x 5 mL 1 1 3
MPNP 1258F BISACODYLbisacodyl 10 mg suppository, 12 3 3 4
MPNP 5304E BISACODYLbisacodyl 10 mg suppository, 12 3 3 3
MPNP 8606Y BISOPROLOLbisoprolol fumarate 10 mg tablet, 28 1 28 5
MPNP 8604W BISOPROLOLbisoprolol fumarate 2.5 mg tablet, 28 1 28 5
MPNP 8605X BISOPROLOLbisoprolol fumarate 5 mg tablet, 28 1 28 5
MPNP 11189X BREXPIPRAZOLEbrexpiprazole 1 mg tablet, 30 1 30 0
MPNP 11190Y BREXPIPRAZOLEbrexpiprazole 3 mg tablet, 30 1 30 5
MPNP 11188W BREXPIPRAZOLEbrexpiprazole 2 mg tablet, 30 1 30 5
MPNP 11184P BREXPIPRAZOLEbrexpiprazole 4 mg tablet, 30 1 30 5
MPNP 11358T BRIVARACETAMbrivaracetam 10 mg/mL oral liquid, 300 mL 1 1 5
MPNP 11357R BRIVARACETAMbrivaracetam 100 mg tablet, 56 1 56 5
MPNP 11350J BRIVARACETAMbrivaracetam 75 mg tablet, 56 1 56 5
MPNP 11327E BRIVARACETAMbrivaracetam 25 mg tablet, 56 1 56 5
MPNP 11338R BRIVARACETAMbrivaracetam 50 mg tablet, 56 1 56 5
MPNP 1444B BROMOCRIPTINEbromocriptine 2.5 mg tablet, 30 1 30 0
MPNP 2070Y BUDESONIDEbudesonide 100 microgram/actuation powder for inhalation, 200 actuations 1 1 5
MPNP 2072C BUDESONIDEbudesonide 400 microgram/actuation powder for inhalation, 200 actuations 1 1 5
MPNP 2071B BUDESONIDEbudesonide 200 microgram/actuation powder for inhalation, 200 actuations 1 1 5
MPNP 2065Q BUDESONIDEbudesonide 500 microgram/2 mL inhalation solution, 30 x 2 mL ampoules 1 1 5
MPNP 10034D BUDESONIDEbudesonide 2 mg/application enema, 2 x 14 applications 1 1 3
MPNP 2066R BUDESONIDEbudesonide 1 mg/2 mL inhalation solution, 30 x 2 mL ampoules 1 1 5
MPNP 10015D BUDESONIDE + FORMOTEROL (EFORMOTEROL)budesonide 100 microgram/actuation + formoterol (eformoterol) fumarate dihydrate 3 microgram/actuation pressurised inhalation, 120 actuations 2 2 5
MPNP 10018G BUDESONIDE + FORMOTEROL (EFORMOTEROL)budesonide 200 microgram/actuation + formoterol (eformoterol) fumarate dihydrate 6 microgram/actuation pressurised inhalation, 120 actuations 2 2 5
MPNP 11273H BUDESONIDE + FORMOTEROL (EFORMOTEROL)budesonide 200 microgram/actuation + formoterol (eformoterol) fumarate dihydrate 6 microgram/actuation powder for inhalation, 120 actuations 1 1 5
MPNP 8625Y BUDESONIDE + FORMOTEROL (EFORMOTEROL)budesonide 200 microgram/actuation + formoterol (eformoterol) fumarate dihydrate 6 microgram/actuation powder for inhalation, 120 actuations 1 1 5
MPNP 8796Y BUDESONIDE + FORMOTEROL (EFORMOTEROL)budesonide 100 microgram/actuation + formoterol (eformoterol) fumarate dihydrate 6 microgram/actuation powder for inhalation, 120 actuations 1 1 5
MPNP 11301T BUDESONIDE + FORMOTEROL (EFORMOTEROL)budesonide 400 microgram/actuation + formoterol (eformoterol) fumarate dihydrate 12 microgram/actuation powder for inhalation, 2 x 60 actuations 1 1 5
MPNP 8750M BUDESONIDE + FORMOTEROL (EFORMOTEROL)budesonide 400 microgram/actuation + formoterol (eformoterol) fumarate dihydrate 12 microgram/actuation powder for inhalation, 2 x 60 actuations 1 1 5
MPNP 10024N BUDESONIDE + FORMOTEROL (EFORMOTEROL)budesonide 50 microgram/actuation + formoterol (eformoterol) fumarate dihydrate 3 microgram/actuation pressurised inhalation, 120 actuations 2 2 5
MPNP 6308B BUPRENORPHINEbuprenorphine 2 mg sublingual tablet, 7 1 7 0
MPNP 10770W BUPRENORPHINEbuprenorphine 15 microgram/hour patch, 2 1 2 0
MPNP 10953L BUPRENORPHINEbuprenorphine 15 microgram/hour patch, 2 2 4 2
MPNP 10756D BUPRENORPHINEbuprenorphine 25 microgram/hour patch, 2 1 2 0
MPNP 10964C BUPRENORPHINEbuprenorphine 25 microgram/hour patch, 2 2 4 2
MPNP 10948F BUPRENORPHINEbuprenorphine 10 microgram/hour patch, 2 2 4 2
MPNP 8866P BUPRENORPHINEbuprenorphine 10 microgram/hour patch, 2 1 2 0
MPNP 10746N BUPRENORPHINEbuprenorphine 40 microgram/hour patch, 2 1 2 0
MPNP 10959T BUPRENORPHINEbuprenorphine 40 microgram/hour patch, 2 2 4 2
MPNP 6309C BUPRENORPHINEbuprenorphine 8 mg tablet, 7 1 7 0
MPNP 10957Q BUPRENORPHINEbuprenorphine 5 microgram/hour patch, 2 2 4 2
MPNP 8865N BUPRENORPHINEbuprenorphine 5 microgram/hour patch, 2 1 2 0
MPNP 6307Y BUPRENORPHINEbuprenorphine 400 microgram sublingual tablet, 7 1 7 0
MPNP 10755C BUPRENORPHINEbuprenorphine 30 microgram/hour patch, 2 1 2 0
MPNP 10949G BUPRENORPHINEbuprenorphine 30 microgram/hour patch, 2 2 4 2
MPNP 10970J BUPRENORPHINEbuprenorphine 20 microgram/hour patch, 2 2 4 2
MPNP 8867Q BUPRENORPHINEbuprenorphine 20 microgram/hour patch, 2 1 2 0
MPNP 9749D BUPRENORPHINE + NALOXONEbuprenorphine 2 mg + naloxone 500 microgram sublingual film, 28 1 28 0
MPNP 9750E BUPRENORPHINE + NALOXONEbuprenorphine 8 mg + naloxone 2 mg sublingual film, 28 1 28 0
MPNP 8710K BUPROPIONbupropion hydrochloride 150 mg modified release tablet, 90 1 90 0
MPNP 8465M BUPROPIONbupropion hydrochloride 150 mg modified release tablet, 30 1 30 0